speb/financial-data huggingface dataset:
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Payables: 2148020000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: -4580000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 362650000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 351530000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Pretax Income: 5054510000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -2730000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: -3540000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -62670000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -9817780000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -511670000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 373070000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 7644290000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1435970000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 271690000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 271690000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -1533370000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 14900000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 15766390000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 9670730000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 8760000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 733490000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1956210000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Share Issued: 166955704.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Special Income Charges: -70000.00
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 217060000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 18492830000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 9967880000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 29427414.72
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Tax Provision: 1431580000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.28
LALPATHLAB.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -1320320000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Total Assets: 24559630000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 18492830000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Total Debt: 2469300000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 18853640000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Total Expenses: 17596290000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 5705990000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 13292660000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1070170000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 132860000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 103900000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 103900000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 529550.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Treasury Stock: 143900000.00
LALPATHLAB.NS balance_sheet (annual, 2024-03-31) — Working Capital: 6631150000.00
LALPATHLAB.NS income_statement (annual, 2024-03-31) — Write Off: 7180000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — +Operating Expense: 2720000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — +Total Revenue: 6602000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 2124000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 901000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 258000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 166494845.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 7.76
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 1568000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 836000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 1068000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 11607000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 836000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 20016000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 14000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Cost Of Revenue: 2210000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 13256000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 600000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 417000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1017000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 4624000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 299000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Depreciation And Amortization In Income Statement: 353000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Depreciation Income Statement: 353000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 166925065.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 7.74
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Diluted NI Availto Com Stockholders: 1292000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — EBIT: 1891000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — EBITDA: 2244000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 5484000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 8274000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 3291000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Gross Profit: 4392000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Interest Expense: 60000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 60000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 468000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 20433000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 335000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 258000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 968000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 968000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 336000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Minority Interests: -16000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Net Income: 1292000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Net Income Common Stockholders: 1292000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Net Income Continuous Operations: 1308000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Net Income From Continuing And Discontinued Operation: 1292000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: 1292000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Net Income Including Noncontrolling Interests: 1308000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Net Interest Income: -60000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: -60000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 3291000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 11742000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 448000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 31000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Normalized EBITDA: 2244000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Normalized Income: 1292000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Operating Income: 1672000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Operating Revenue: 6602000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 166592772.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 270000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 364000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 19180000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 2790000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 33000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 219000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Other Operating Expenses: 1127000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 3277000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 10000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 10539000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Otherunder Preferred Stock Dividend: 0.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Payables: 2411000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Pretax Income: 1831000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Reconciled Cost Of Revenue: 2210000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 353000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 167148504.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 20016000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 11742000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Tax Provision: 523000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Tax Rate For Calcs: 0.29
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 25975000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 20016000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 1985000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 20352000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-09-30) — Total Expenses: 4930000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 5623000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 12719000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 999000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 287000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Treasury Shares Number: 555732.00
LALPATHLAB.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 8632000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 2745000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 5967000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 166724138.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 5.80
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 2037000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 355000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 355000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 167012090.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 5.79
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 967000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — EBIT: 1436000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — EBITDA: 1791000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 3930000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 53000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 53000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Minority Interests: -14000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Net Income: 967000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 967000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 981000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 967000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 967000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 981000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -53000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -53000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 1791000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 967000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Operating Income: 1185000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 5967000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 251000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 1126000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 1383000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 2037000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 355000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 402000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.29
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 4782000000.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
LALPATHLAB.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — +Operating Expense: 10809120000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 2744000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — +Total Revenue: 24612220000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 6026000000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1670500000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1670500000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 881210000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 881210000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -5220640000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -5220640000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 1257300000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1257300000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -287840000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -287840000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Amortization: 606910000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 606910000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 676580000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 676580000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 166585974.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 166630786.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Basic EPS: 29.24
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 9.29
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 3609330000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 4693660000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 4693660000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -538740000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 1574300000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1574300000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 835920000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 835920000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 2926260000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2926260000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 11640720000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 11640720000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -2072990000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 2685920000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 2685920000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 240340000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 240340000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 11750000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -36720000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 121180000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Change In Payable: 122820000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -151110000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 11200000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -683070000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Common Stock: 835920000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 835920000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -2072990000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 21727150000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 21727150000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 127040000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 68570000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 68570000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 4814640000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1178000000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Current Assets: 13635090000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 13635090000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 547940000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 547940000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Current Debt: 0.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 0.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 547940000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 547940000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 4023530000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4023530000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 352000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 352000000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Deferred Tax: 1325470000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Depreciation: 812310000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 1419220000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 1419220000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 364000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 812310000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 364000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 166836368.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 166990291.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Diluted EPS: 29.20
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 9.27
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 4871380000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 1548000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — EBIT: 6471040000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — EBIT: 1584000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — EBITDA: 7890260000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — EBITDA: 1948000000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — End Cash Position: 2926260000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -3340290000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 5150110000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -209300000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 21510000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 1615250000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Goodwill: 5481130000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 5481130000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 7991850000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 7991850000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 1169050000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1169050000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 8647250000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 8647250000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Gross Profit: 19797580000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 4848000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Interest Expense: 223050000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 50000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 223050000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 50000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Interest Income: 664580000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 664580000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -223050000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 631180000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Inventory: 361320000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 361320000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 21727150000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 21727150000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -3031630000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 333580000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 333580000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 676580000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 676580000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 127040000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 269830000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 269830000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 1026360000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1026360000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1026360000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1026360000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -833340000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 19000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 19000000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 3615190000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3615190000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 337630000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 337630000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Minority Interests: -51140000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Minority Interests: -7000000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 127040000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 110000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Net Income: 4871380000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Net Income: 1548000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 4871380000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 1548000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 4922520000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1555000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 4871380000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1548000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 4871380000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1548000000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 4922520000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 4922520000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1555000000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -95800000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Net Interest Income: 441530000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -50000000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -3165530000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -833340000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -833340000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 441530000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -50000000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 34720000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Net PPE: 3426610000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 3426610000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -436200000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 13735300000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 13735300000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 866160000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 866160000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 33730000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 33730000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 19470000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 19470000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 140460000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 140460000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 7710370000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1948000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Normalized Income: 4729652480.78
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 1548000000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 5688850000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Operating Income: 8988460000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Operating Income: 2104000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Operating Revenue: 24612220000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 6026000000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 166734546.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 166734546.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 224000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 224000000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 431000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 431000000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 566400000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 566400000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 2510720000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2510720000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -479600000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 5180000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 5180000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: -3361890000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -520000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 2134200000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1296000000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Other Payable: 598910000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 598910000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Other Properties: 3358000000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 3358000000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 357050000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 357050000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 8714460000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 8714460000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Other Special Charges: 18160000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Payables: 2407880000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Payables: 2407880000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: -48950000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 351470000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 351470000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 381760000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 381760000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Pretax Income: 6247990000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 1534000000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 34480000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -95800000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -15721020000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -442940000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 361320000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 361320000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 4814640000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1178000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 1419220000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 364000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 305980000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 305980000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -833340000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 13030000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 13030000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 18599580000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 18599580000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 12555490000.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 6740000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 778410000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 2393660000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Share Issued: 167183470.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 167183470.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Special Income Charges: -29410000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 270950000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 21727150000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 21727150000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 13735300000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 13735300000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 38162480.78
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Tax Provision: 1325470000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -21000000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.21
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
LALPATHLAB.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -1638960000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Total Assets: 27167870000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 27167870000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 21727150000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 21727150000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Total Debt: 1574300000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1574300000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 22064780000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 22064780000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Total Expenses: 15623760000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 3922000000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 5103090000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 5103090000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 13532780000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 13532780000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1079560000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1079560000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 138470000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 138470000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 179890000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 179890000.00
LALPATHLAB.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Treasury Shares Number: 448924.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 448924.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Treasury Stock: 194810000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 194810000.00
LALPATHLAB.NS balance_sheet (annual, 2025-03-31) — Working Capital: 9611560000.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 9611560000.00
LALPATHLAB.NS income_statement (annual, 2025-03-31) — Write Off: 11250000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 2874000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 6698000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 166750630.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 7.94
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2247000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 346000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 346000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 166960908.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 7.93
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1324000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — EBIT: 1858000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — EBITDA: 2204000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 4451000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 47000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 47000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Minority Interests: -16000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Net Income: 1324000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1324000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1340000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1324000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1324000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1340000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -47000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -47000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2204000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 1324000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Operating Income: 1577000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 6698000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 281000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1285000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 1811000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2247000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 346000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 471000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 5121000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
LALPATHLAB.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
LALPATHLAB.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 166869806.00
LALPATHLAB.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 9.03
LALPATHLAB.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 167240422.00
LALPATHLAB.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 9.01
LALPATHLAB.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 166934206.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 167551020.00
LALPATHLAB.NS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 616814.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 2981000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 6598000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 166974170.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 5.42
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2245000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 421000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 421000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 167282810.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 5.41
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 905000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — EBIT: 1315000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — EBITDA: 1736000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 4353000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 72000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 72000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -9000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Net Income: 905000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 905000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 914000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 905000000.00
LALPATHLAB.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 905000000.00